- Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
-
Rhee J, Jo J, Han SH, Kwon JM
- KMID: 2439066
- Ann Dermatol.
- 2019 Apr;31(2):201-203.
- doi: 10.5021/ad.2019.31.2.201
No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies: colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Capecitabine and Cisplatin-induced Cutaneous Hyperpigmentation
-
Hwang SH, Park JH, Choi CW, Lee GY, Kim WS
- KMID: 2246384
- Korean J Dermatol.
- 2014 Mar;52(3):210-212.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hand-foot Syndrome Due to Capecitabine
-
Choi CW, Huh CH
- KMID: 2302592
- Korean J Dermatol.
- 2005 Jul;43(7):965-968.
Hand-foot syndrome, also known as acral erythema, is a distinctive and relatively common toxic reaction due to some anticancer drugs. It is characterized by a painful erythema on the palms... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential Diagnosis between Hand-foot Syndrome and Gout in Colorectal Cancer with Capecitabine: A Case Study and Review of the Literature
-
Park JY
- KMID: 2269468
- Asian Oncol Nurs.
- 2014 Mar;14(1):1-6.
- doi: 10.5388/aon.2014.14.1.1
PURPOSE: This study is to present a case of a patient experiencing foot pain after being prescribed capecitabine and to review the differential diagnosis between hand-foot syndrome and gout. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution
-
Lee KH, Kim JS, Kim JY
- KMID: 2354325
- Ann Surg Treat Res.
- 2016 Oct;91(4):178-186.
- doi: 10.4174/astr.2016.91.4.178
PURPOSE: Oral capecitabine has demonstrated to be safe and efficient as neoadjuvant concurrent chemoradiotherapy (NCRT) for locally advanced rectal cancers. The aim of this study was to evaluate the long-term... -
- CITED
-
- Close
- SHARE
-
- Close
- Cessation or dose reduction of Capecitabine due to Complications in Patients with Colon Cancer
-
Sohn SK
- KMID: 2198782
- J Korean Soc Coloproctol.
- 2010 Aug;26(4):240-240.
- doi: 10.3393/jksc.2010.26.4.240
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
-
Jung YH, Lee WJ, Byeon JH, Lee IK, Han CW, Woo IS
- KMID: 2411497
- Korean J Intern Med.
- 2017 Sep;32(5):926-929.
- doi: 10.3904/kjim.2015.049
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Aortic Thrombosis Following Capecitabine Chemotherapy in a Patient with Colon Cancer
-
Lee MK, Kim EY, Kim YS, Sym SJ, Kim JH
- KMID: 2418658
- J Korean Soc Radiol.
- 2018 Sep;79(3):166-170.
- doi: 10.3348/jksr.2018.79.3.166
The elevated risk for thromboembolic events in cancer patients has been well documented. Chemotherapy is considered to be one of the most important risk factors for cardiovascular complications such as... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Capecitabine-Induced Sarcoidosis
-
Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS
- KMID: 2319803
- Tuberc Respir Dis.
- 2012 Mar;72(3):318-322.
Sarcoidosis is an inflammatory disease involving multiple-organs with an unknown cause. The new onset of sarcoidosis associated with therapeutic agents has been observed in 3 clinical settings; tumor necrosis factor... -
- CITED
-
- Close
- SHARE
-
- Close
- The Schedule Dependency for Induction of Thymidine Phosphorylase Activity and the Enhancement of Capecitabine Efficacy by Docetaxel on the SNU-484 Gastric Cancer Cell Line That was Injected into Xenografted Nude Mice
-
Suh SB, Suh BJ, Kim JH, Yoo HJ
- KMID: 2211126
- J Korean Surg Soc.
- 2007 Oct;73(4):294-301.
PURPOSE: Docetaxel (Taxotere(R)) and capecitabine are used in combination to treat advanced gastric cancer. Thymidine phosphorylase (TP) is an essential enzyme for the activation of capecitabine in tumors. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes
-
Park SW, Kim JS, Kim JY, Lee KH
- KMID: 2412400
- Ann Surg Treat Res.
- 2018 Jun;94(6):306-311.
- doi: 10.4174/astr.2018.94.6.306
PURPOSE: The aim of this study was to evaluate the long-term outcome of additional 4-week chemotherapy with capecitabine during the resting periods following a 6-week neoadjuvant chemoradiotherapy (NCRT) regimen, in... -
- CITED
-
- Close
- SHARE
-
- Close
- Nasolacrimal Duct Stenosis after Oral Capecitabine Administration
-
Jang Y, Kim N, Lee KW, Choung HK, Khwarg SI
- KMID: 2434310
- Korean J Ophthalmol.
- 2019 Feb;33(1):95-96.
- doi: 10.3341/kjo.2018.0113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Timing for the Administration of Capecitabine with Preoperative Chemoradiation for Locally Advanced Rectal Cancer
-
Noh YJ, Choi WS, Kim JH, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM, Ryu MH, Ahn SD, Lee SW, Shin SS, Lee JE, Choi EK
- KMID: 2166090
- Cancer Res Treat.
- 2006 Feb;38(1):30-34.
PURPOSE: Capecitabine is an oral fluoropyrimidine carbamate and it is known as an effective radiosensitizer. Capecitabine and its metabolite reach their peak concentration in the plasma at 1~2 hours after... -
- CITED
-
- Close
- SHARE
-
- Close
- Hand-foot Syndrome Following Capecitabine (Xeloda(R)) Monotherapy for Colorectal Cancer
-
Park SD, Lee KY, Park SJ, Lee SH, Lee SM
- KMID: 2334441
- J Korean Soc Coloproctol.
- 2009 Aug;25(4):227-233.
PURPOSE: Capecitabine (Xeloda(R)), which is a systemic prodrug of 5-fluorouracil, can be used in oral formulation for treatment of advanced colorectal cancer as a 1st line or an alternative modality... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
-
Lee KH, Song MS, Park JB, Kim JS, Kang DY, Kim JY
- KMID: 2263891
- Ann Coloproctol.
- 2013 Oct;29(5):192-197.
- doi: 10.3393/ac.2013.29.5.192
PURPOSE: The aim of this study is to evaluate the efficacy and the safety of additional 4-week chemotherapy with capecitabine during the resting periods after a 6-week neoadjuvant chemoradiotherapy (NCRT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer
-
Kim YJ, Kim JH, Yu CS, Kim TW, Jang SJ, Choi EK, Kim JC, Choi W
- KMID: 2386210
- Radiat Oncol J.
- 2017 Jun;35(2):129-136.
- doi: 10.3857/roj.2017.00010
PURPOSE: The concentration of capecitabine peaks at 1–2 hours after administration. We therefore assumed that proper timing of capecitabine administration and radiotherapy would maximize radiosensitization and influence survival among patients... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
-
Choi JG, Seo JH, Oh SC, Choi CW, Kim JS
- KMID: 2167598
- Cancer Res Treat.
- 2012 Jun;44(2):127-132.
PURPOSE: The purpose of this study was to determine the efficacy and safety of treatment using gemcitabine and capecitabine for patients with advanced pancreatic cancer. MATERIALS AND METHODS: Patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Capecitabine-based Neoadjuvant Chemoradiation Therapy in Locally-advanced Rectal Cancer
-
Choi HJ, Park KJ, Lee TM, Ha SS, Lee HY, Lee HS
- KMID: 2198813
- J Korean Soc Coloproctol.
- 2010 Apr;26(2):137-144.
- doi: 10.3393/jksc.2010.26.2.137
PURPOSE: The aim of the study was to evaluate the efficacy and the toxicity of preoperative treatment with capecitabine in combination with radiation therapy (RT) in patients with locally-advanced, resectable... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Complete Response with Lapatinib Plus Capecitabine in a Patient with HER2-Positive Breast Cancer Metastasized to the Pancreas
-
Shin K, Kim J, Yoon S, Cho EH, Jung C, Kang HJ
- KMID: 2171353
- Ewha Med J.
- 2015 Oct;38(3):138-143.
- doi: 10.12771/emj.2015.38.3.138
A 37-year-old woman underwent a total mastectomy and adjuvant chemotherapy for HER2-positive breast cancer (pT1N0M), and then recurred in the right lung followed by the pancreas. Lung lobectomy and pylorus-preserving... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
-
Yun JA, Kim HC, Son HS, Kim HR, Yun HR, Cho YB, Yun SH, Lee WY, Chun HK
- KMID: 2198790
- J Korean Soc Coloproctol.
- 2010 Aug;26(4):287-292.
- doi: 10.3393/jksc.2010.26.4.287
PURPOSE: Oral capecitabine has been used as adjuvant therapy for colorectal cancer patients since the 1990s. Patient-initiated cessation or reduced use of capecitabine occurs widely for various reasons, yet the... -
- CITED
-
- Close
- SHARE
-
- Close
